别名:RGL1; RHG09; rho GTPase activating 9;应用:WB
反应种属:Human
规格:50μl/100μl
Description |
---|
GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. Has a substantial GAP activity toward CDC42 and RAC1 and less toward RHOA. Has a role in regulating adhesion of hematopoietic cells to the extracellular matrix. Binds phosphoinositides, and has the highest affinity for phosphatidylinositol 3,4,5-trisphosphate, followed by phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 4,5-bisphosphate.Furukawa Y., Biochem. Biophys. Res. Commun. 284:643-649(2001).The MGC Project Team, Genome Res. 14:2121-2127(2004).Kawasoe T., Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases. |
Specification | |
---|---|
Aliases | RGL1; RHG09; rho GTPase activating 9; |
Entrez GeneID | 64333; |
Swissprot | Q9BRR9 |
WB Predicted band size | 90kDa |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | Synthesized peptide derived from internal of human RHG9. |
Formulation | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Application | |
---|---|
WB | 1/500-1/3000 |
![]() |
Western blot analysis of extracts from LOVO cells, using RHG9 antibody P42567. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
发表回复